Omnicell Vs. Sarepta Therapeutics Industry Stock Comparison

Sell

44

OMCL
Omnicell

Last Price:

43.02

Seasonality Move:

-3.72%

Sell

36

SRPT
Sarepta Therapeutics

Last Price:

124.65

Seasonality Move:

-1.39%

Sell

44

Omnicell (OMCL) is a Sell

Is Omnicell a Buy, Sell or Hold?

The current Omnicell [OMCL] share price is $43.02. The Score for OMCL is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
OMCL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

36

Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OMCL Stock Price Chart

What is Omnicell's stock price today?

The Omnicell share price today is $43.02
The current trend is relatively stagnant and OMCL is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

The Sarepta Therapeutics share price today is $124.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

OMCL Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.52	Buy
Relative Strength Index (14 RSI):	51.53	Buy
Chaikin Money Flow:	-111787	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(43.05 - 45.03)	Sell
Bollinger Bands (100):	(27.57 - 41.85)	Buy

SRPT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-3.18	Sell
Relative Strength Index (14 RSI):	35.54	Sell
Chaikin Money Flow:	-49995	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(124.27 - 135.95)	Sell
Bollinger Bands (100):	(123.89 - 147.49)	Sell

OMCL Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	43.23	Sell
20-day SMA:	43.74	Sell
50-day SMA:	40.42	Buy
200-day SMA:	32.7	Buy
8-day EMA:	43.18	Sell
20-day EMA:	43.21	Sell
50-day EMA:	40.43	Buy
200-day EMA:	37.24	Buy

SRPT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	125.45	Sell
20-day SMA:	127.75	Sell
50-day SMA:	135.2	Sell
200-day SMA:	127.53	Sell
8-day EMA:	125.39	Sell
20-day EMA:	128.04	Sell
50-day EMA:	132.59	Sell
200-day EMA:	128.64	Sell

Omnicell Earnings Growth & OMCL Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.31 per share, and an increase next year of $0.15 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Omnicell Technical Analysis

	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20	Sep 23	Sep 24	Sep 25	Sep 26	Sep 27
	Sep
	16	17	18	19	20	23	24	25	26	27
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20	Sep 23	Sep 24	Sep 25	Sep 26	Sep 27
	Sep
	16	17	18	19	20	23	24	25	26	27
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):